Loading…
Tumour necrosis factor‐α as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat
The cytokine tumour necrosis factor‐α (TNF‐α) is involved (mostly through the activation of inducible nitric oxide synthase) in the pathogenesis of circulatory shock. On the other hand, melanocortin peptides are potent and effective in reversing haemorrhagic shock, both in animals (rat, dog) and in...
Saved in:
Published in: | British journal of pharmacology 1998-08, Vol.124 (8), p.1587-1590 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4588-f876229ba1638f4fb35c41ac2d2c95c132a7aa22965b2e9646e3ed941cd9669a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4588-f876229ba1638f4fb35c41ac2d2c95c132a7aa22965b2e9646e3ed941cd9669a3 |
container_end_page | 1590 |
container_issue | 8 |
container_start_page | 1587 |
container_title | British journal of pharmacology |
container_volume | 124 |
creator | Altavilla, Domenica Cainazzo, Maria‐Michela Squadrito, Francesco Guarini, Salvatore Bertolini, Alfio Bazzani, Carla |
description | The cytokine tumour necrosis factor‐α (TNF‐α) is involved (mostly through the activation of inducible nitric oxide synthase) in the pathogenesis of circulatory shock. On the other hand, melanocortin peptides are potent and effective in reversing haemorrhagic shock, both in animals (rat, dog) and in humans. This prompted us to study the influence of the melanocortin peptide ACTH‐(1–24) on the blood levels of TNF‐α in haemorrhage‐shocked rats and on the in vitro production of TNF‐α by lipopolysaccharide (LPS)‐activated macrophages. Plasma levels of TNF‐α were undetectable before starting bleeding and greatly increased 20 min after bleeding termination in saline‐treated rats. In rats treated with ACTH‐(1–24) the almost complete restoration of cardiovascular function was associated with markedly reduced levels of TNF‐α 20 min after bleeding termination. On the other hand, ACTH‐(1–24) did not influence TNF‐α plasma levels in sham‐operated, unbled rats. In vitro, ACTH‐(1–24) (25–100 nM) dose‐dependently reduced the LPS‐stimulated production of TNF‐α by peritoneal macrophages harvested from untreated, unbled rats. These results indicate that inhibition of TNF‐α overproduction may be an important component of the mechanism of action of melanocortins in reversing haemorrhagic shock.
British Journal of Pharmacology (1998) 124, 1587–1590; doi:10.1038/sj.bjp.0702038 |
doi_str_mv | 10.1038/sj.bjp.0702038 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1565580</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73965282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4588-f876229ba1638f4fb35c41ac2d2c95c132a7aa22965b2e9646e3ed941cd9669a3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS1EVYbClh2SF4gVmfon_skGqVRAK1Uqi7K2bhxn4iGJBzsBlRWPwKvwIjwET4JHE41gxcr2PZ_P9fVB6Bkla0q4Pk_bdb3drYkiLB8foBUtlSwE1_QhWhFCVEGp1o_Q45S2hGRRiVN0WikhuWIr1N3NQ5gjHp2NIfmEW7BTiL-___j1E0PCgCeIGzfh0OLB9TAGG-Lkx4T9iDtwQ4ixg423OHXBfnq1L0-dwzCCS3kz-W-uwRGmJ-ikhT65p8t6hj6-e3t3eVXc3L6_vry4KWwptC5arSRjVQ1Uct2Wbc2FLSlY1jBbCUs5AwWQCSlq5ipZSsddU5XUNpWUFfAz9Prgu5vrwTXWjVOE3uyiHyDemwDe_KuMvjOb8MVQIYXQJBu8XAxi-DznIczgk3V9nt2FORnFc2-mWQbXB3D_cym69tiEErPPxqStydmYJZt84fnfTzviSxhZf7HokCz0bYTR-nTEWEmkIDxj_IB99b27_09T8-bDlVBE8z942qv7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73965282</pqid></control><display><type>article</type><title>Tumour necrosis factor‐α as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat</title><source>Wiley-Blackwell Read & Publish Collection</source><source>PubMed Central</source><creator>Altavilla, Domenica ; Cainazzo, Maria‐Michela ; Squadrito, Francesco ; Guarini, Salvatore ; Bertolini, Alfio ; Bazzani, Carla</creator><creatorcontrib>Altavilla, Domenica ; Cainazzo, Maria‐Michela ; Squadrito, Francesco ; Guarini, Salvatore ; Bertolini, Alfio ; Bazzani, Carla</creatorcontrib><description>The cytokine tumour necrosis factor‐α (TNF‐α) is involved (mostly through the activation of inducible nitric oxide synthase) in the pathogenesis of circulatory shock. On the other hand, melanocortin peptides are potent and effective in reversing haemorrhagic shock, both in animals (rat, dog) and in humans. This prompted us to study the influence of the melanocortin peptide ACTH‐(1–24) on the blood levels of TNF‐α in haemorrhage‐shocked rats and on the in vitro production of TNF‐α by lipopolysaccharide (LPS)‐activated macrophages. Plasma levels of TNF‐α were undetectable before starting bleeding and greatly increased 20 min after bleeding termination in saline‐treated rats. In rats treated with ACTH‐(1–24) the almost complete restoration of cardiovascular function was associated with markedly reduced levels of TNF‐α 20 min after bleeding termination. On the other hand, ACTH‐(1–24) did not influence TNF‐α plasma levels in sham‐operated, unbled rats. In vitro, ACTH‐(1–24) (25–100 nM) dose‐dependently reduced the LPS‐stimulated production of TNF‐α by peritoneal macrophages harvested from untreated, unbled rats. These results indicate that inhibition of TNF‐α overproduction may be an important component of the mechanism of action of melanocortins in reversing haemorrhagic shock.
British Journal of Pharmacology (1998) 124, 1587–1590; doi:10.1038/sj.bjp.0702038</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0702038</identifier><identifier>PMID: 9756372</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adrenocorticotropin ; Anesthesia ; Animals ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Pressure - drug effects ; Cardiology. Vascular system ; Cosyntropin - pharmacology ; Depression, Chemical ; Dose-Response Relationship, Drug ; Female ; haemorrhagic shock ; Heart Rate - drug effects ; macrophages ; Male ; Medical sciences ; Miscellaneous ; rat ; Rats ; Rats, Wistar ; Respiratory Mechanics - drug effects ; Shock, Hemorrhagic - metabolism ; Shock, Hemorrhagic - physiopathology ; Special Report ; Tumor Necrosis Factor-alpha - biosynthesis ; tumour necrosis factor‐α</subject><ispartof>British journal of pharmacology, 1998-08, Vol.124 (8), p.1587-1590</ispartof><rights>1998 British Pharmacological Society</rights><rights>1998 INIST-CNRS</rights><rights>Copyright 1998, Nature Publishing Group 1998 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4588-f876229ba1638f4fb35c41ac2d2c95c132a7aa22965b2e9646e3ed941cd9669a3</citedby><cites>FETCH-LOGICAL-c4588-f876229ba1638f4fb35c41ac2d2c95c132a7aa22965b2e9646e3ed941cd9669a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1565580/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1565580/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2406503$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9756372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Altavilla, Domenica</creatorcontrib><creatorcontrib>Cainazzo, Maria‐Michela</creatorcontrib><creatorcontrib>Squadrito, Francesco</creatorcontrib><creatorcontrib>Guarini, Salvatore</creatorcontrib><creatorcontrib>Bertolini, Alfio</creatorcontrib><creatorcontrib>Bazzani, Carla</creatorcontrib><title>Tumour necrosis factor‐α as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>The cytokine tumour necrosis factor‐α (TNF‐α) is involved (mostly through the activation of inducible nitric oxide synthase) in the pathogenesis of circulatory shock. On the other hand, melanocortin peptides are potent and effective in reversing haemorrhagic shock, both in animals (rat, dog) and in humans. This prompted us to study the influence of the melanocortin peptide ACTH‐(1–24) on the blood levels of TNF‐α in haemorrhage‐shocked rats and on the in vitro production of TNF‐α by lipopolysaccharide (LPS)‐activated macrophages. Plasma levels of TNF‐α were undetectable before starting bleeding and greatly increased 20 min after bleeding termination in saline‐treated rats. In rats treated with ACTH‐(1–24) the almost complete restoration of cardiovascular function was associated with markedly reduced levels of TNF‐α 20 min after bleeding termination. On the other hand, ACTH‐(1–24) did not influence TNF‐α plasma levels in sham‐operated, unbled rats. In vitro, ACTH‐(1–24) (25–100 nM) dose‐dependently reduced the LPS‐stimulated production of TNF‐α by peritoneal macrophages harvested from untreated, unbled rats. These results indicate that inhibition of TNF‐α overproduction may be an important component of the mechanism of action of melanocortins in reversing haemorrhagic shock.
British Journal of Pharmacology (1998) 124, 1587–1590; doi:10.1038/sj.bjp.0702038</description><subject>Adrenocorticotropin</subject><subject>Anesthesia</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiology. Vascular system</subject><subject>Cosyntropin - pharmacology</subject><subject>Depression, Chemical</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>haemorrhagic shock</subject><subject>Heart Rate - drug effects</subject><subject>macrophages</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>rat</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Respiratory Mechanics - drug effects</subject><subject>Shock, Hemorrhagic - metabolism</subject><subject>Shock, Hemorrhagic - physiopathology</subject><subject>Special Report</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>tumour necrosis factor‐α</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAUhS1EVYbClh2SF4gVmfon_skGqVRAK1Uqi7K2bhxn4iGJBzsBlRWPwKvwIjwET4JHE41gxcr2PZ_P9fVB6Bkla0q4Pk_bdb3drYkiLB8foBUtlSwE1_QhWhFCVEGp1o_Q45S2hGRRiVN0WikhuWIr1N3NQ5gjHp2NIfmEW7BTiL-___j1E0PCgCeIGzfh0OLB9TAGG-Lkx4T9iDtwQ4ixg423OHXBfnq1L0-dwzCCS3kz-W-uwRGmJ-ikhT65p8t6hj6-e3t3eVXc3L6_vry4KWwptC5arSRjVQ1Uct2Wbc2FLSlY1jBbCUs5AwWQCSlq5ipZSsddU5XUNpWUFfAz9Prgu5vrwTXWjVOE3uyiHyDemwDe_KuMvjOb8MVQIYXQJBu8XAxi-DznIczgk3V9nt2FORnFc2-mWQbXB3D_cym69tiEErPPxqStydmYJZt84fnfTzviSxhZf7HokCz0bYTR-nTEWEmkIDxj_IB99b27_09T8-bDlVBE8z942qv7</recordid><startdate>199808</startdate><enddate>199808</enddate><creator>Altavilla, Domenica</creator><creator>Cainazzo, Maria‐Michela</creator><creator>Squadrito, Francesco</creator><creator>Guarini, Salvatore</creator><creator>Bertolini, Alfio</creator><creator>Bazzani, Carla</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199808</creationdate><title>Tumour necrosis factor‐α as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat</title><author>Altavilla, Domenica ; Cainazzo, Maria‐Michela ; Squadrito, Francesco ; Guarini, Salvatore ; Bertolini, Alfio ; Bazzani, Carla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4588-f876229ba1638f4fb35c41ac2d2c95c132a7aa22965b2e9646e3ed941cd9669a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adrenocorticotropin</topic><topic>Anesthesia</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiology. Vascular system</topic><topic>Cosyntropin - pharmacology</topic><topic>Depression, Chemical</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>haemorrhagic shock</topic><topic>Heart Rate - drug effects</topic><topic>macrophages</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>rat</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Respiratory Mechanics - drug effects</topic><topic>Shock, Hemorrhagic - metabolism</topic><topic>Shock, Hemorrhagic - physiopathology</topic><topic>Special Report</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>tumour necrosis factor‐α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Altavilla, Domenica</creatorcontrib><creatorcontrib>Cainazzo, Maria‐Michela</creatorcontrib><creatorcontrib>Squadrito, Francesco</creatorcontrib><creatorcontrib>Guarini, Salvatore</creatorcontrib><creatorcontrib>Bertolini, Alfio</creatorcontrib><creatorcontrib>Bazzani, Carla</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Altavilla, Domenica</au><au>Cainazzo, Maria‐Michela</au><au>Squadrito, Francesco</au><au>Guarini, Salvatore</au><au>Bertolini, Alfio</au><au>Bazzani, Carla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumour necrosis factor‐α as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1998-08</date><risdate>1998</risdate><volume>124</volume><issue>8</issue><spage>1587</spage><epage>1590</epage><pages>1587-1590</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>The cytokine tumour necrosis factor‐α (TNF‐α) is involved (mostly through the activation of inducible nitric oxide synthase) in the pathogenesis of circulatory shock. On the other hand, melanocortin peptides are potent and effective in reversing haemorrhagic shock, both in animals (rat, dog) and in humans. This prompted us to study the influence of the melanocortin peptide ACTH‐(1–24) on the blood levels of TNF‐α in haemorrhage‐shocked rats and on the in vitro production of TNF‐α by lipopolysaccharide (LPS)‐activated macrophages. Plasma levels of TNF‐α were undetectable before starting bleeding and greatly increased 20 min after bleeding termination in saline‐treated rats. In rats treated with ACTH‐(1–24) the almost complete restoration of cardiovascular function was associated with markedly reduced levels of TNF‐α 20 min after bleeding termination. On the other hand, ACTH‐(1–24) did not influence TNF‐α plasma levels in sham‐operated, unbled rats. In vitro, ACTH‐(1–24) (25–100 nM) dose‐dependently reduced the LPS‐stimulated production of TNF‐α by peritoneal macrophages harvested from untreated, unbled rats. These results indicate that inhibition of TNF‐α overproduction may be an important component of the mechanism of action of melanocortins in reversing haemorrhagic shock.
British Journal of Pharmacology (1998) 124, 1587–1590; doi:10.1038/sj.bjp.0702038</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>9756372</pmid><doi>10.1038/sj.bjp.0702038</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 1998-08, Vol.124 (8), p.1587-1590 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1565580 |
source | Wiley-Blackwell Read & Publish Collection; PubMed Central |
subjects | Adrenocorticotropin Anesthesia Animals Biological and medical sciences Blood and lymphatic vessels Blood Pressure - drug effects Cardiology. Vascular system Cosyntropin - pharmacology Depression, Chemical Dose-Response Relationship, Drug Female haemorrhagic shock Heart Rate - drug effects macrophages Male Medical sciences Miscellaneous rat Rats Rats, Wistar Respiratory Mechanics - drug effects Shock, Hemorrhagic - metabolism Shock, Hemorrhagic - physiopathology Special Report Tumor Necrosis Factor-alpha - biosynthesis tumour necrosis factor‐α |
title | Tumour necrosis factor‐α as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T23%3A55%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumour%20necrosis%20factor%E2%80%90%CE%B1%20as%20a%20target%20of%20melanocortins%20in%20haemorrhagic%20shock,%20in%20the%20anaesthetized%20rat&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Altavilla,%20Domenica&rft.date=1998-08&rft.volume=124&rft.issue=8&rft.spage=1587&rft.epage=1590&rft.pages=1587-1590&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1038/sj.bjp.0702038&rft_dat=%3Cproquest_pubme%3E73965282%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4588-f876229ba1638f4fb35c41ac2d2c95c132a7aa22965b2e9646e3ed941cd9669a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73965282&rft_id=info:pmid/9756372&rfr_iscdi=true |